原发性硬化性胆管炎合并2型糖尿病患者糖皮质激素和胰岛素的合理应用经验

doi:10.3969/j.issn.1672-5069.2016.06.033

JOURNAL OF PRACTICAL HEPATOLOGY ›› 2016, Vol. 19 ›› Issue (6): 745-746.doi: 10.3969/j.issn.1672-5069.2016.06.033

Previous Articles Next Articles

Glucocorticoid application and glucose management in patients with primary sclerosing cholangitis complicated by type 2 diabetes mellitus

Zhang Tingting，Kang Yaojie，Wang Xuan.

Department of Endocrinology and Metabolism Diseases，302nd Hospital，Beijing 100038，China

Received:2016-03-22 Online:2016-11-10 Published:2016-11-28
Contact: Wang Xuan，E-mail:endocrine@163.com

Abstract

Zhang Tingting，Kang Yaojie，Wang Xuan.. Glucocorticoid application and glucose management in patients with primary sclerosing cholangitis complicated by type 2 diabetes mellitus[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 745-746.

[1]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[2]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[3]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[4]	Pang Xiaoning，Liu Yanjun.. A comparative study of liraglutide,sitagliptin and pioglitazone in the treatment of patients with nonalcoholic fatty liver diseases and type 2 diabetes mellitus [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 604-605.
[5]	Liu Xiaoni, Wang Ying, Li Taotao, et al.. Pathological changes of liver tissues in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 420-423.
[6]	Zhang Xin.. Efficacy and safety of glucocorticoids in treatment of patients with hepatic failure:A Meta-analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 73-77.
[7]	Long Yun,Liu Yunhua,Deng Lan,et al.. Efficacy and safety of glucocorticoid-decreasing-dose therapy in patients with hepatitis B-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 297-300.
[8]	Ai Yuemei,Yan Yujuan,Xing Yiping. Autoimmune liver diseases: the mist really clears? [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 360-364.
[9]	Jiang Xiang, Wang Qixia, Ma Xiong. What's going on in dignosis and treatment of patients with autoimmune liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 15-19.
[10]	Zhu Ping, Deng Guojiong, Chen Jianxin. Early administration of glucocorticoid improves prognosis of patients with liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 650-652.
[11]	Xu Liang, Mi Yuqiang. Progress in treatment of alcoholic liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(1): 89-91.
[12]	LI Jing，WANG Luwen，Gong Zuojiong. Efficacy and safety of glucocorticoids on patients with severe viral hepatitis:A Meta-analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(2): 121-123.

Glucocorticoid application and glucose management in patients with primary sclerosing cholangitis complicated by type 2 diabetes mellitus

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 12

Recommended Articles

Metrics

Comments